肝硬化腹水并原发性腹膜炎88例临床分析

肝硬化腹水并发原发性腹膜炎(SBP)是肝硬化晚期严重并发症和主要死亡原因之一。因早期症状不典型而易误诊。本文对我们1982～1990年间收治的88例作一总结,并对早期诊断及预防作一讨论。     

精神分裂症病人康复期的家庭治疗与护理

精神分裂症的复发是精神科临床常常面临的棘手问题.该病由于反复发病或迁延不愈常残留慢性症状或人格障碍.要使病人最大限度地康复,待出院后尚需要长时间的继续服药.一般来讲,初次治愈者继续服药时间不能少于5年,多次治愈者应终生服药,以巩固其治疗效果及预防复发.精神症状基本稳定的康复期病人有较强的康复出院回归社会的愿望,在这段期间,病人往往不愿意服药,而如果停药或受到精神刺激则极易导致病情复发.     

HER-2/neu基因表达对Ⅲ期非小细胞肺癌化疗敏感性的影响

【目的】探讨HER 2 /neu基因表达对Ⅲ期NSCLC化疗敏感性的影响。【方法】对 2 2例中晚期NSCLC患者术前化疗后行手术治疗 ,标本采用免疫组化法进行HER 2 /neu检测 ,分析HER 2 /neu与化疗显效率、疾病进展时间 (TTP)的关系。【结果】 2 2例患者围手术期无 1例死亡。HER 2 /neu( ) 9例 ,HER 2 /neu( -) 13例。HER 2 /neu( )组中化疗有效率为 44 4% ,HER 2 /neu( -)组则为 30 7%。经 χ2 检验P值 0 416 ;HER 2 /neu( )组与阴性组其TTP亦无显著性差异 (P为 0 5 11)。【结论】HER 2 /neu可能不是独立的化疗敏感性的预测因子 ,仍需开展进一步实验。     

人工全髋关节置换术围手术期的康复和护理

随着老龄人口的增加,人工全髋关节置换术的病例数逐年上升.成功的手术、围手术期良好的康复以及护理是获得良好的术后效果的关键.本文对全髋关节置换术的基本知识、围手术期的康复以及护理方法进行了综述.     

Iq7611放射增敏治疗食管癌的效果观察

Iq7611是天津市医药科学研究所研制的醌类成份放射增敏药物。初步实验室研究表明可降低细胞氧耗量,增加氧分压,又可降低癌细胞谷胱甘肽的含量,使癌细胞丧失或减少了对射线的防护能力。自1982年2月到1984年12月,在我院临床应用。进行了62     

传统草药("汉方药")与药物性肝损害

一、何谓“汉方药”？ “汉方药”（漠方蕖）是由数种生药组合而成，各药分量是遵古方所载，业已沿用数百乃至两千余年的传统方剂。某些煎剂（依现代技术制成）现亦列入日本医保范畴。     

其他

由中华医学会骨科分会骨质疏松学组主办、吉林省医学会骨科分会及吉林大学第一医院骨关节一科承办的“2007中国长春国际骨质疏松性骨折高层论坛”于2007年7月21日—22日在长春南湖宾馆隆重召开,包括骨质疏松学组全体委员在内的全国各地200余名代表出席了大会并参加了学术研讨和     

升主动脉成形术中期效果分析

Objective Reduction ascending aortoplasty is an alternative procdure to the replacement of the ascending aorts in case of ascending aorta dilation. However,its applicabikity is still under debate.This retrospective study was designed to evaluuate the midterm follow-up of unsupported ascending reduction aortoplasty for of the ascending aorta in petients with aortic valve dis- ease.Methods From October ,1996 to April,2007, a total of 54 patients with aortic valve disease and dilatation of the ascending aorta underwent unsupported reduction aortoplasty in combination with aortic valve replacement at our institution The diameter of the ascending aorta was measyred before and early after sugery and then later between 13 and 96 menths [mean (23 ±16)months] posto- perativeiy using echocardiography.Results Two patients were dead with thean overall perioperative mortality rate was of 3.7%. The reduction aortoplasty decreased the diameter of the aorta from (45.77±6.02) mm p～eope～afive]y to (34.67 ～4.81) mm early after surgery (P<0.01). During follow-up, the diameter d aorta increased from (34.67±4.81) mm early after surgery to (37.65± 6.35) mm after a mean follow-up of (23±16) months (P<0.01), including the diameters are greater than > 45 mm within 5 pa- tients. Aortic stenosis and an early postoperative diameter greater than 40 mm m'e independent risk factors for redilatation. Conchusion Because of the unsatisfied midterm follow-up redilation of unsupported reduction aortoplasty for dilation of the ascending aorta with aortic valve disease, this group of patients needs continued intimate fallow-up or even reoperation. The patients of stenosis is the surtable indication for RAA, and it is necessary to reduce the diameter of aorta to be lees than 40 mm to prevent redilation.